We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brant Inman

Brant A. Inman MD, MS

Cary N. Robertson Associate Professor and Co-Director of the Center of Prostate and Urologic Cancers at the Duke Cancer Institute of Duke University, Durham, NC

Brant A. Inman, MD, MS is Cary N. Robertson Associate Professor and Co-Director of the Center of Prostate and Urologic Cancers at the Duke Cancer Institute of Duke University. His area of clinical expertise is the surgical treatment of genitourinary cancers, with a particular emphasis on bladder cancer and advanced malignancies. From a research standpoint, Dr. Inman has a translational laboratory that is focused on novel therapies and diagnostic tests for genitourinary cancer as relates to immunotherapy and heat targeted therapies. He is principal investigator on several clinical trials of new therapies for urologic cancers.

Dr. Inman is a member of Board of Directors of the Society of Urologic Oncology Clinical Trials Consortium, a member of the National Comprehensive Cancer Network bladder cancer panel, a member of the Research Council and Research Grants and Investigator Support Committee of the American Urological Association, and Associate Editor of European Urology Focus.